- Home
- TSHA vs FLXS Comparison
TSHA vs FLXS Comparison
Compare TSHA & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- FLXS
- Stock Information
- Founded
- TSHA 2019
- FLXS 2001
- Country
- TSHA United States
- FLXS United States
- Employees
- TSHA N/A
- FLXS N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- FLXS Home Furnishings
- Sector
- TSHA Health Care
- FLXS Consumer Discretionary
- Exchange
- TSHA Nasdaq
- FLXS Nasdaq
- Market Cap
- TSHA 403.7M
- FLXS 324.1M
- IPO Year
- TSHA 2020
- FLXS N/A
- Fundamental
- Price
- TSHA $2.00
- FLXS $61.10
- Analyst Decision
- TSHA Strong Buy
- FLXS
- Analyst Count
- TSHA 8
- FLXS 0
- Target Price
- TSHA $6.63
- FLXS N/A
- AVG Volume (30 Days)
- TSHA 5.4M
- FLXS 35.3K
- Earning Date
- TSHA 11-13-2024
- FLXS 02-03-2025
- Dividend Yield
- TSHA N/A
- FLXS 1.10%
- EPS Growth
- TSHA N/A
- FLXS N/A
- EPS
- TSHA N/A
- FLXS 2.50
- Revenue
- TSHA $9,915,000.00
- FLXS $422,156,000.00
- Revenue This Year
- TSHA N/A
- FLXS $7.03
- Revenue Next Year
- TSHA N/A
- FLXS $4.99
- P/E Ratio
- TSHA N/A
- FLXS $24.91
- Revenue Growth
- TSHA N/A
- FLXS 7.53
- 52 Week Low
- TSHA $1.19
- FLXS $17.20
- 52 Week High
- TSHA $4.32
- FLXS $65.87
- Technical
- Relative Strength Index (RSI)
- TSHA 41.45
- FLXS 55.72
- Support Level
- TSHA $1.97
- FLXS $58.82
- Resistance Level
- TSHA $2.72
- FLXS $65.87
- Average True Range (ATR)
- TSHA 0.23
- FLXS 1.95
- MACD
- TSHA -0.10
- FLXS -0.20
- Stochastic Oscillator
- TSHA 2.24
- FLXS 33.93
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.